November 18, 2026
Health news, explained with evidence
LIVE

Analytical Report: Avian Virus Adaptation in Immunocompromised Patients

🧠 AI Analysis 2 min read 👁 3

A fatal case of Newcastle disease virus in a cancer patient reveals how advanced immunotherapies may allow animal pathogens to mutate and cross into humans.

Analytical Report: Avian Virus Adaptation in Immunocompromised Patients🧠AI Analysis

Photo: Medical Xpress

Key points

  • A poultry-borne virus caused a fatal brain infection in a patient treated with the bispecific antibody teclistamab.
  • The virus adapted to the human nervous system through a process of hypermutation similar to the measles virus.
  • Metagenomic sequencing was required to identify the pathogen after standard diagnostic tests failed.

An analytical review of a recent case study from the University Medical Center Hamburg-Eppendorf (UKE) identifies a significant diagnostic challenge in modern oncology: the emergence of zoonotic infections during intensive immunotherapy. The study, published in Acta Neuropathologica, details a fatal instance of encephalitis in a multiple myeloma patient caused by the Newcastle disease virus (NDV), a pathogen typically restricted to avian populations.

Viral Adaptation and Hypermutation

The patient was undergoing treatment with teclistamab, a bispecific antibody that redirects T-cells to attack cancer cells. While effective against malignancies, this treatment appears to have created an immunological environment allowing NDV to cross the species barrier. Genomic analysis revealed that the virus underwent "hypermutation," a process of rapid genetic change that allowed it to adapt to the human central nervous system, mirroring patterns seen in chronic measles infections.

The identification of the virus was only made possible through metagenomic sequencing, which scans all genetic material in a sample without pre-selecting for specific microbes. This unbiased approach bypassed the limitations of standard diagnostic panels, which do not typically screen for avian pathogens in human patients. The findings suggest that as immunotherapies become more advanced, the spectrum of potential opportunistic infections may expand to include viruses previously considered harmless to humans.

The researchers noted that this is not an isolated instance of animal-to-human viral transmission in clinical settings. A similar case in France recently involved the Shamonda virus, another animal pathogen that caused fatal encephalitis in an immunocompromised individual. In both instances, metagenomic sequencing was the pivotal tool in identifying the cause of death where traditional methods failed.

What to know: This case emphasizes the importance of advanced genetic sequencing in diagnosing unexplained neurological symptoms in immunocompromised individuals. Patients undergoing immunotherapy should maintain close communication with their healthcare providers regarding any new or unusual symptoms. Always consult a medical professional for personal health decisions.

Source Medical Xpress — medicalxpress.com/news/2026-11-unusual-pathogen-fatal-viral-infection.h… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.